Key Takeaway
TENS significantly reduces pain intensity, disability, and improves quality of life in fibromyalgia patients compared to control interventions.
Summary
This systematic review and meta-analysis evaluated the effectiveness of transcutaneous electrical nerve stimulation (TENS) for treating fibromyalgia syndrome, a chronic condition characterized by widespread pain, fatigue, and reduced quality of life.
The researchers analyzed randomized controlled trials comparing TENS to sham or other interventions in fibromyalgia patients. The meta-analysis found that TENS produced statistically significant improvements in pain intensity, functional disability, and overall quality of life measures.
These findings support TENS as a non-pharmacological treatment option for fibromyalgia, offering benefits without the side effects associated with medications commonly prescribed for this condition.
Methods
- Systematic review following PRISMA guidelines
- Searched multiple databases for randomized controlled trials
- Included studies comparing TENS to sham TENS or other control interventions
- Outcomes assessed: pain intensity, disability, quality of life
- Meta-analysis conducted using standardized mean differences
- Risk of bias assessed using Cochrane tools
Key Results
- TENS significantly reduced pain intensity compared to control groups
- Significant improvements in disability scores
- Quality of life measures improved with TENS treatment
- Effects observed across multiple assessment timepoints
- Low to moderate heterogeneity across included studies
Limitations
- Varying TENS protocols across studies (frequency, intensity, duration)
- Relatively small sample sizes in some included trials
- Short follow-up periods in most studies
- Potential for blinding issues with sham TENS comparisons
- Limited data on long-term effectiveness